electroCore Provides Update on 510(k) Submission Seeking Expanded Indication for gammaCore™

Ads

You May Also Like

Basilea’s antifungal CRESEMBA(r) (isavuconazole) launched in Italy

BASEL, Switzerland, June 27, 2016 (GLOBE NEWSWIRE) -- Basilea Pharmaceutica Ltd. (SIX: BSLN) announces ...

Telix Pharmaceuticals Acquires Glioblastoma Program from Therapeia

MELBOURNE, Australia and DRESDEN, Germany, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited ...